(Q48846829)

16 February 2018

title

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus. (English)

1 reference

16 February 2018

0 references

Wolfgang Brück

1

1 reference

16 February 2018

Timothy Vollmer

series ordinal

2

1 reference

16 February 2018

language of work or name

English

0 references

publication date

26 November 2013

1 reference

16 February 2018

published in

Nature Reviews Neurology

1 reference

16 February 2018

volume

9

1 reference

16 February 2018

issue

12

1 reference

16 February 2018

page(s)

664-665

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1038/nrneurol.2013.234

exact match

0 references

cites work

Placebo-controlled trial of oral laquinimod for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

Pathology and disease mechanisms in different stages of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

Therapeutic decisions in multiple sclerosis: moving beyond efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.234

10.1038/NRNEUROL.2013.234

31 March 2020

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018